In accordance to plan SCN has now received and delivered the first order from Aerus, SCN’s new Immulina partner, on totally USD 480 000 with cash payment. Aerus has also committed to purchase Immulina at a value of MSEK 250 during the coming five years in order to maintain the world-wide distribution rights. SCN also expects others order of the same size during this year.
As a consequence of this agreement and other actions that have been taken and implemented during the last six months, the SCN management believes that positive cash flow will be shown during the third and fourth quarter.